IP Library Granted Patent US 8,426,574
Granted Patent B2
US 8,426,574 · App. 12/790,618 · Granted Apr 23, 2013

Identification of astrovirus VA1 associated with gastroenteritis in humans

Inventors: David Wang (St. Louis, MO); Herbert Whiting Virgin, IV (St. Louis, MO); Guoyan Zhao (St. Louis, MO); Stacy Finkbeiner (St. Louis, MO); Jan Vinje (Decatur, GA); Yan Li (Tucker, GA); Suxiang Tong (Duluth, GA)
Assignees: Washington University; The United States of America, as Represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,426,574
App. No.
12/790,618
Granted
Apr 23, 2013
Kind
B2
Abstract

Provided herein is a novel human astrovirus, its nucleic acid sequence, as well as methods to detect and diagnose the presence of the astrovirus.

Claims (8)

1. An isolated nucleic acid molecule comprising a nucleotide sequence at least 95% identical to SEQ ID NO:1, or a complement to the entire said nucleotide sequence.

2. The isolated nucleic acid molecule of claim 1 wherein said nucleotide sequence is at least 98% identical to SEQ ID NO:1, or is a complement to the entire said nucleotide sequence.

3. The isolated nucleic acid molecule of claim 1 wherein said nucleotide sequence is identical to SEQ ID NO:1, or is a complement to the entire said nucleotide sequence.

4. A vector comprising the nucleotide sequence of claim 3 or a complement to the entire said nucleotide sequence.

5. An isolated cell comprising the vector of claim 4 .

6. A method to detect the presence of AstV-VA1 in a sample which method comprises contacting the sample with a probe that specifically hybridizes under stringent conditions to the nucleic acid molecule of claim 5 , or

which method comprises contacting the sample with amplification primers, amplifying nucleic acid in the sample, contacting the amplified nucleic acid with a probe that specifically hybridizes under stringent conditions to the nucleic acid molecule of claim 5 ,

wherein said stringent conditions are 6×SSC at about 45° C. followed by one or more washes of about 5-30 min each in 0.1×SSC, 0.1% SDS at 45-65° C.

Assignments (3)
CONFIRMATORY LICENSE Recorded Mar 31, 2017
From: WASHINGTON UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 042125/0708 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 21, 2010
From: TONG, SUXIANG; VINJE, JAN; LI, YAN
To: THE GOVERNMENT OF THE UNITED STATES OF AMERICA, SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION
Reel/Frame 025023/0749 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 21, 2010
From: WANG, DAVID; ZHAO, GUOYAN; VIRGIN IV, HERBERT W.; FINKBEINER, STACY
To: WASHINGTON UNIVERSITY
Reel/Frame 025023/0760 →
Continuity (2)
Provisional Application 61182008 · May 28, 2009
Related Publication 20110008353A1 · Jan 13, 2011